Evidence map›Paper›PMID 38536971›Full record

ArticleEinstein (Sao Paulo, Brazil)2024

Quality of life of women who underwent breast cancer treatment relative to sociodemographic, behavioral, and clinical factors.

Angélica Atala Lombelo Campos, Maria Teresa Bustamante-Teixeira, Rafaela Russi Ervilha, Vivian Assis Fayer, Jane Rocha Duarte Cintra, Renata Mendes de Freitas, Daniela Pereira de Almeida, Maximiliano Ribeiro Guerra

Open access · diamondAbstract read
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Angélica Atala Lombelo CamposUniversidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0001-8406-6370
Maria Teresa Bustamante-TeixeiraUniversidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0003-0727-4170
Rafaela Russi ErvilhaUniversidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0001-7899-4875
Vivian Assis FayerPrograma de Pós Graduação em Saúde Coletiva, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0003-2529-5039
Jane Rocha Duarte CintraInstituto Oncológico, Hospital Nove de Julho, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0003-3090-3297
Renata Mendes de FreitasPrograma de Pós Graduação em Saúde Coletiva, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0002-6694-371X
Daniela Pereira de AlmeidaUniversidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0003-1048-1859
Maximiliano Ribeiro GuerraUniversidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID http://orcid.org/0000-0003-0234-7190
Universidade Federal de Juiz de Fora · BRHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePatients with cancer often undergo multiple extended treatments that decrease their quality of life. However, the quality of life of women with breast cancer after they undergo treatment remains underexplored in Brazil. Therefore, this study determined sociodemographic, behavioral, and clinical factors related to the post-treatment quality of life of women with breast cancer.

methodsThis cross-sectional study involved 101 women diagnosed with breast cancer between 2014 and 2016 and treated at a Brazilian Oncology Reference Service. Data were collected from them using face-to-face surveys. Quality of life was evaluated using the European Organization for the Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC QLQ-C30) and EORTC Breast Cancer-specific Quality of Life questionnaire (EORTC QLQ-BR23). The data collected were analyzed using Student's t-test and Mann-Whitney U test.

resultsThe median score on the global health, functional, and symptom scales of the EORTC QLQ-C30 was 75.00 (Interquartile range=33.33), 75.99 (Standard deviation [SD]=19.26), and 19.67 (SD=16.91), respectively. The mean score on the functional and symptom scales of the EORTC QLQ-BR23 was 61.89 (SD=17.21) and 20.12 (SD=16.94), respectively. Furthermore, higher post-treatment quality of life was found to be associated with being aged 50 or more, being Black, having eight or more years of education, having a partner, having a paying job, receiving treatment from the private healthcare system, having a higher income, living in the municipality where healthcare services are availed, engaging in physical activity, not smoking, being more religious, having more social support, not being overweight, having no comorbidities, and undergoing lumpectomy.

conclusionSociodemographic, behavioral, and clinical factors significantly impact the quality of life of women who undergo breast cancer treatment. Implementing interventions that improve health and reducing inequalities in the access to healthcare services can improve the quality of life of these patients.

backgroundSociodemographic, clinical, and lifestyle factors impact the quality of life of breast cancer survivors.

backgroundBreast cancer therapy may affect future perspectives and emotional, cognitive, and sexual function.

backgroundSome aspects of quality of life still require attention from health professionals.

backgroundHigher post-treatment quality of life of women with breast cancer is linked to being aged 50 or more, being Black, having 8 or more years of education, having a partner, having a paying job, receiving care from private healthcare, having a high per capita income, residing in the municipality where the service is availed, engaging in physical activity, not smoking, greater religiosity, having more social support, having a normal weight, having no comorbidities, and undergoing lumpectomy.

Indexed as

Breast NeoplasmsQuality of LifeCross-Sectional StudiesFemaleHumansSurveys and QuestionnairesSurvivors

Identifiers

PMID38536971
PMCPMC10948096
OpenAlexW4392847650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.